Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 302

1.

Efficacy of Home-Based Telerehabilitation vs In-Clinic Therapy for Adults After Stroke: A Randomized Clinical Trial.

Cramer SC, Dodakian L, Le V, See J, Augsburger R, McKenzie A, Zhou RJ, Chiu NL, Heckhausen J, Cassidy JM, Scacchi W, Smith MT, Barrett AM, Knutson J, Edwards D, Putrino D, Agrawal K, Ngo K, Roth EJ, Tirschwell DL, Woodbury ML, Zafonte R, Zhao W, Spilker J, Wolf SL, Broderick JP, Janis S; National Institutes of Health StrokeNet Telerehab Investigators.

JAMA Neurol. 2019 Jun 24. doi: 10.1001/jamaneurol.2019.1604. [Epub ahead of print]

PMID:
31233135
2.

Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registry.

Robinson TG, Bray BD, Paley L, Sprigg N, Wang X, Arima H, Bath PM, Broderick JP, Durham AC, Kim JS, Lavados PM, Lee TH, Martins S, Nguyen TH, Pandian JD, Parsons MW, Pontes-Neto OM, Ricci S, Sharma VK, Wang J, Woodward M, Rudd AG, Chalmers J, S Anderson C; ENCHANTED Investigators and the SSNAP Collaboration.

Int J Stroke. 2019 Apr 8:1747493019841246. doi: 10.1177/1747493019841246. [Epub ahead of print]

PMID:
30961463
3.

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.

Anderson CS, Huang Y, Lindley RI, Chen X, Arima H, Chen G, Li Q, Billot L, Delcourt C, Bath PM, Broderick JP, Demchuk AM, Donnan GA, Durham AC, Lavados PM, Lee TH, Levi C, Martins SO, Olavarria VV, Pandian JD, Parsons MW, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Silva F, Song L, Thang NH, Wardlaw JM, Wang JG, Wang X, Woodward M, Chalmers J, Robinson TG; ENCHANTED Investigators and Coordinators.

Lancet. 2019 Mar 2;393(10174):877-888. doi: 10.1016/S0140-6736(19)30038-8. Epub 2019 Feb 7.

PMID:
30739745
4.

Abstract 79: Chronic and Acute Hypertension in Ischemic Stroke Are Distinct Markers of Impaired Collateral Circulation.

Liebeskind DS, Ayata C, Brown S, Raychev R, Scalzo F, Broderick JP, Tomsick TA, Cipolla MJ.

Stroke. 2018 Jan 22;49(Suppl_1):A79. doi: 10.1161/str.49.suppl_1.79.

PMID:
30520353
5.

The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods.

Kamel H, Longstreth WT Jr, Tirschwell DL, Kronmal RA, Broderick JP, Palesch YY, Meinzer C, Dillon C, Ewing I, Spilker JA, Di Tullio MR, Hod EA, Soliman EZ, Chaturvedi S, Moy CS, Janis S, Elkind MS.

Int J Stroke. 2019 Feb;14(2):207-214. doi: 10.1177/1747493018799981. Epub 2018 Sep 10.

PMID:
30196789
6.

Endovascular Treatment in the DEFUSE 3 Study.

Marks MP, Heit JJ, Lansberg MG, Kemp S, Christensen S, Derdeyn CP, Rasmussen PA, Zaidat OO, Broderick JP, Yeatts SD, Hamilton S, Mlynash M, Albers GW; DEFUSE 3 Investigators.

Stroke. 2018 Aug;49(8):2000-2003. doi: 10.1161/STROKEAHA.118.022147.

PMID:
29986935
7.

To Treat or Not to Treat?

Levine SR, Weingast SZ, Weedon J, Stefanov DG, Katz P, Hurley D, Kasner SE, Khatri P, Broderick JP, Grotta JC, Feldmann E, Panagos PD, Romano JG, Bianchi R, Meyer BC, Scott PA, Kim D, Balucani C.

Stroke. 2018 Aug;49(8):1933-1938. doi: 10.1161/STROKEAHA.118.020971.

PMID:
29976582
8.

Bayesian selective response-adaptive design using the historical control.

Kim MO, Harun N, Liu C, Khoury JC, Broderick JP.

Stat Med. 2018 Nov 20;37(26):3709-3722. doi: 10.1002/sim.7836. Epub 2018 Jun 13.

9.

Prehospital Triage of Acute Ischemic Stroke Patients to an Intravenous tPA-Ready versus Endovascular-Ready Hospital: A Decision Analysis.

Benoit JL, Khatri P, Adeoye OM, Broderick JP, McMullan JT, Scheitz JF, Vagal AS, Eckman MH.

Prehosp Emerg Care. 2018 Nov-Dec;22(6):722-733. doi: 10.1080/10903127.2018.1465500. Epub 2018 May 30.

PMID:
29847193
10.

Haemostatic treatment for intracerebral haemorrhage.

Broderick JP.

Lancet. 2018 May 26;391(10135):2081-2082. doi: 10.1016/S0140-6736(18)31040-7. Epub 2018 May 16. No abstract available.

11.

Lipid-Lowering Pretreatment and Outcome Following Intravenous Thrombolysis for Acute Ischaemic Stroke: A Post Hoc Analysis of the Enhanced Control of Hypertension and Thrombolysis Stroke Study Trial.

Minhas JS, Wang X, Arima H, Bath PM, Billot L, Broderick JP, Donnan GA, Kim JS, Lavados PM, Lee TH, Martins SCO, Olavarría VV, Pandian JD, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Thang NH, Wang JG, Woodward M, Chalmers J, Anderson CS, Robinson TG; ENCHANTED Investigators.

Cerebrovasc Dis. 2018;45(5-6):213-220. doi: 10.1159/000488911. Epub 2018 Apr 27.

PMID:
29705803
12.

PFO Closure for Cryptogenic Stroke.

Mi MY, Block PC, Broderick JP.

N Engl J Med. 2018 Apr 26;378(17):1639-1642. doi: 10.1056/NEJMclde1715853. No abstract available.

PMID:
29694824
13.

Pediatric Stroke Rates Over 17 Years: Report From a Population-Based Study.

Lehman LL, Khoury JC, Taylor JM, Yeramaneni S, Sucharew H, Alwell K, Moomaw CJ, Peariso K, Flaherty M, Khatri P, Broderick JP, Kissela BM, Kleindorfer DO.

J Child Neurol. 2018 Jun;33(7):463-467. doi: 10.1177/0883073818767039. Epub 2018 Apr 19.

14.

Alteplase for the treatment of acute ischemic stroke in patients with low National Institutes of Health Stroke Scale and not clearly disabling deficits (Potential of rtPA for Ischemic Strokes with Mild Symptoms PRISMS): Rationale and design.

Yeatts SD, Broderick JP, Chatterjee A, Jauch EC, Levine SR, Romano JG, Saver JL, Vagal A, Purdon B, Devenport J, Khatri P.

Int J Stroke. 2018 Aug;13(6):654-661. doi: 10.1177/1747493018765269. Epub 2018 Mar 23.

PMID:
29570044
15.

Heritability of circle of Willis variations in families with intracranial aneurysms.

Sánchez van Kammen M, Moomaw CJ, van der Schaaf IC, Brown RD Jr, Woo D, Broderick JP, Mackey JS, Rinkel GJE, Huston J 3rd, Ruigrok YM.

PLoS One. 2018 Jan 29;13(1):e0191974. doi: 10.1371/journal.pone.0191974. eCollection 2018.

16.

Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.

Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, McTaggart RA, Torbey MT, Kim-Tenser M, Leslie-Mazwi T, Sarraj A, Kasner SE, Ansari SA, Yeatts SD, Hamilton S, Mlynash M, Heit JJ, Zaharchuk G, Kim S, Carrozzella J, Palesch YY, Demchuk AM, Bammer R, Lavori PW, Broderick JP, Lansberg MG; DEFUSE 3 Investigators.

N Engl J Med. 2018 Feb 22;378(8):708-718. doi: 10.1056/NEJMoa1713973. Epub 2018 Jan 24.

17.

Design and rationale for examining neuroimaging genetics in ischemic stroke: The MRI-GENIE study.

Giese AK, Schirmer MD, Donahue KL, Cloonan L, Irie R, Winzeck S, Bouts MJRJ, McIntosh EC, Mocking SJ, Dalca AV, Sridharan R, Xu H, Frid P, Giralt-Steinhauer E, Holmegaard L, Roquer J, Wasselius J, Cole JW, McArdle PF, Broderick JP, Jimenez-Conde J, Jern C, Kissela BM, Kleindorfer DO, Lemmens R, Lindgren A, Meschia JF, Rundek T, Sacco RL, Schmidt R, Sharma P, Slowik A, Thijs V, Woo D, Worrall BB, Kittner SJ, Mitchell BD, Rosand J, Golland P, Wu O, Rost NS.

Neurol Genet. 2017 Aug 24;3(5):e180. doi: 10.1212/NXG.0000000000000180. eCollection 2017 Oct.

18.

Soluble ST2 predicts outcome and hemorrhagic transformation after acute stroke.

Wolcott Z, Batra A, Bevers MB, Sastre C, Khoury J, Sperling M, Meyer BC, Walsh KB, Adeoye O, Broderick JP, Kimberly WT.

Ann Clin Transl Neurol. 2017 Jul 5;4(8):553-563. doi: 10.1002/acn3.435. eCollection 2017 Aug.

19.

Sex-specific stroke incidence over time in the Greater Cincinnati/Northern Kentucky Stroke Study.

Madsen TE, Khoury J, Alwell K, Moomaw CJ, Rademacher E, Flaherty ML, Woo D, Mackey J, De Los Rios La Rosa F, Martini S, Ferioli S, Adeoye O, Khatri P, Broderick JP, Kissela BM, Kleindorfer D.

Neurology. 2017 Sep 5;89(10):990-996. doi: 10.1212/WNL.0000000000004325. Epub 2017 Aug 9.

20.

Translational Stroke Research: Vision and Opportunities.

Bosetti F, Koenig JI, Ayata C, Back SA, Becker K, Broderick JP, Carmichael ST, Cho S, Cipolla MJ, Corbett D, Corriveau RA, Cramer SC, Ferguson AR, Finklestein SP, Ford BD, Furie KL, Hemmen TM, Iadecola C, Jakeman LB, Janis S, Jauch EC, Johnston KC, Kochanek PM, Kohn H, Lo EH, Lyden PD, Mallard C, McCullough LD, McGavern LM, Meschia JF, Moy CS, Perez-Pinzon MA, Ramadan I, Savitz SI, Schwamm LH, Steinberg GK, Stenzel-Poore MP, Tymianski M, Warach S, Wechsler LR, Zhang JH, Koroshetz W.

Stroke. 2017 Sep;48(9):2632-2637. doi: 10.1161/STROKEAHA.117.017112. Epub 2017 Jul 27. Review. No abstract available.

21.

Estimated Impact of Emergency Medical Service Triage of Stroke Patients on Comprehensive Stroke Centers: An Urban Population-Based Study.

Katz BS, Adeoye O, Sucharew H, Broderick JP, McMullan J, Khatri P, Widener M, Alwell KS, Moomaw CJ, Kissela BM, Flaherty ML, Woo D, Ferioli S, Mackey J, Martini S, De Los Rios la Rosa F, Kleindorfer DO.

Stroke. 2017 Aug;48(8):2164-2170. doi: 10.1161/STROKEAHA.116.015971. Epub 2017 Jul 12.

22.

Practice Patterns for Acute Ischemic Stroke Workup: A Longitudinal Population-Based Study.

Loftspring MC, Kissela BM, Flaherty ML, Khoury JC, Alwell K, Moomaw CJ, Kleindorfer DO, Woo D, Adeoye O, Ferioli S, Broderick JP, Khatri P.

J Am Heart Assoc. 2017 Jun 23;6(6). pii: e005097. doi: 10.1161/JAHA.116.005097.

23.

Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials.

Broderick JP, Adeoye O, Elm J.

Stroke. 2017 Jul;48(7):2007-2012. doi: 10.1161/STROKEAHA.117.017866. Epub 2017 Jun 16. Review. No abstract available.

24.

Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study).

Robinson TG, Wang X, Arima H, Bath PM, Billot L, Broderick JP, Demchuk AM, Donnan GA, Kim JS, Lavados PM, Lee TH, Lindley RI, Martins SCO, Olavarria VV, Pandian JD, Parsons MW, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Nguyen TH, Wang JG, Woodward M, Chalmers J, Anderson CS; ENCHANTED Investigators.

Stroke. 2017 Jul;48(7):1877-1883. doi: 10.1161/STROKEAHA.116.016274. Epub 2017 Jun 15.

PMID:
28619989
25.

Endovascular Therapy Demonstrates Benefit over Intravenous Recombinant Tissue Plasminogen Activator Based on Repeatedly Measured National Institutes of Health Stroke Scale.

Fan L, Yeatts SD, Foster LD, Khatri P, Tomsick T, Broderick JP, Palesch YY.

Interv Neurol. 2017 Mar;6(1-2):25-30. doi: 10.1159/000452137. Epub 2016 Oct 19.

26.

Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III.

Simpson KN, Simpson AN, Mauldin PD, Palesch YY, Yeatts SD, Kleindorfer D, Tomsick TA, Foster LD, Demchuk AM, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, von Kummer R, Molina CA, Goyal M, Schonewille WJ, Mazighi M, Engelter ST, Anderson C, Spilker J, Carrozzella J, Ryckborst KJ, Janis LS, Broderick JP; Interventional Management of Stroke (IMS) III Investigators.

J Am Heart Assoc. 2017 May 8;6(5). pii: e004513. doi: 10.1161/JAHA.116.004513.

27.

Biomarkers of Acute Stroke Etiology (BASE) Study Methodology.

Jauch EC, Barreto AD, Broderick JP, Char DM, Cucchiara BL, Devlin TG, Haddock AJ, Hicks WJ, Hiestand BC, Jickling GC, June J, Liebeskind DS, Lowenkopf TJ, Miller JB, O'Neill J, Schoonover TL, Sharp FR, Peacock WF.

Transl Stroke Res. 2017 May 5. doi: 10.1007/s12975-017-0537-3. [Epub ahead of print]

28.

Reply.

Tomsick TA, Liebeskind DS, Hill MD, von Kummer R, Goyal M, Broderick JP.

AJNR Am J Neuroradiol. 2017 Jun;38(6):E44-E45. doi: 10.3174/ajnr.A5200. Epub 2017 May 4. No abstract available.

29.

Selection of patients for intra-arterial treatment for acute ischaemic stroke: development and validation of a clinical decision tool in two randomised trials.

Venema E, Mulder MJHL, Roozenbeek B, Broderick JP, Yeatts SD, Khatri P, Berkhemer OA, Emmer BJ, Roos YBWEM, Majoie CBLM, van Oostenbrugge RJ, van Zwam WH, van der Lugt A, Steyerberg EW, Dippel DWJ, Lingsma HF.

BMJ. 2017 May 3;357:j1710. doi: 10.1136/bmj.j1710.

30.

Towards personalised intra-arterial treatment of patients with acute ischaemic stroke: a study protocol for development and validation of a clinical decision aid.

Mulder MJ, Venema E, Roozenbeek B, Broderick JP, Yeatts SD, Khatri P, Berkhemer OA, Roos YB, Majoie CB, van Oostenbrugge RJ, van Zwam WH, van der Lugt A, Steyerberg EW, Dippel DW, Lingsma HF.

BMJ Open. 2017 Mar 22;7(3):e013699. doi: 10.1136/bmjopen-2016-013699.

31.

American Stroke Association Stroke Council Update.

Derdeyn CP, Broderick JP, Furie K.

Stroke. 2017 Apr;48(4):e108-e109. doi: 10.1161/STROKEAHA.117.016049. Epub 2017 Mar 10. Review. No abstract available.

PMID:
28283603
32.

Teaching NeuroImages: Crying thalamus: Manifestation of acute ischemic stroke.

Obeidat AZ, Broderick JP.

Neurology. 2017 Feb 28;88(9):e72-e73. doi: 10.1212/WNL.0000000000003664. No abstract available.

33.

Stroke Recovery and Rehabilitation Research: Issues, Opportunities, and the National Institutes of Health StrokeNet.

Cramer SC, Wolf SL, Adams HP Jr, Chen D, Dromerick AW, Dunning K, Ellerbe C, Grande A, Janis S, Lansberg MG, Lazar RM, Palesch YY, Richards L, Roth E, Savitz SI, Wechsler LR, Wintermark M, Broderick JP.

Stroke. 2017 Mar;48(3):813-819. doi: 10.1161/STROKEAHA.116.015501. Epub 2017 Feb 7. No abstract available.

34.

Severe carotid stenosis and delay of reperfusion in endovascular stroke treatment: an Interventional Management of Stroke-III study.

Gogela SL, Gozal YM, Zhang B, Tomsick TA, Ringer AJ, Broderick JP, Khatri P, Abruzzo TA.

J Neurosurg. 2018 Jan;128(1):94-99. doi: 10.3171/2016.9.JNS161044. Epub 2017 Feb 3.

PMID:
28156253
35.

Clinical Selection Strategies to Identify Ischemic Stroke Patients With Large Anterior Vessel Occlusion: Results From SITS-ISTR (Safe Implementation of Thrombolysis in Stroke International Stroke Thrombolysis Registry).

Scheitz JF, Abdul-Rahim AH, MacIsaac RL, Cooray C, Sucharew H, Kleindorfer D, Khatri P, Broderick JP, Audebert HJ, Ahmed N, Wahlgren N, Endres M, Nolte CH, Lees KR; SITS Scientific Committee.

Stroke. 2017 Feb;48(2):290-297. doi: 10.1161/STROKEAHA.116.014431. Epub 2017 Jan 13. Erratum in: Stroke. 2017 Mar;48(3):e95.

PMID:
28087804
36.

Power of an Adaptive Trial Design for Endovascular Stroke Studies: Simulations Using IMS (Interventional Management of Stroke) III Data.

Lansberg MG, Bhat NS, Yeatts SD, Palesch YY, Broderick JP, Albers GW, Lai TL, Lavori PW.

Stroke. 2016 Dec;47(12):2931-2937. Epub 2016 Nov 15.

37.

Recanalization and Angiographic Reperfusion Are Both Associated with a Favorable Clinical Outcome in the IMS III Trial.

Schmitz ML, Yeatts SD, Tomsick TA, Liebeskind DS, Vagal A, Broderick JP, Khatri P.

Interv Neurol. 2016 Sep;5(3-4):118-122. Epub 2016 Jun 16.

38.

Stable incidence but declining case-fatality rates of subarachnoid hemorrhage in a population.

Mackey J, Khoury JC, Alwell K, Moomaw CJ, Kissela BM, Flaherty ML, Adeoye O, Woo D, Ferioli S, De Los Rios La Rosa F, Martini S, Khatri P, Broderick JP, Zuccarello M, Kleindorfer D.

Neurology. 2016 Nov 22;87(21):2192-2197. Epub 2016 Oct 21.

39.

Endovascular Therapy of M2 Occlusion in IMS III: Role of M2 Segment Definition and Location on Clinical and Revascularization Outcomes.

Tomsick TA, Carrozzella J, Foster L, Hill MD, von Kummer R, Goyal M, Demchuk AM, Khatri P, Palesch Y, Broderick JP, Yeatts SD, Liebeskind DS; IMS III Investigators.

AJNR Am J Neuroradiol. 2017 Jan;38(1):84-89. doi: 10.3174/ajnr.A4979. Epub 2016 Oct 20.

40.

Potentially Missed Diagnosis of Ischemic Stroke in the Emergency Department in the Greater Cincinnati/Northern Kentucky Stroke Study.

Madsen TE, Khoury J, Cadena R, Adeoye O, Alwell KA, Moomaw CJ, McDonough E, Flaherty ML, Ferioli S, Woo D, Khatri P, Broderick JP, Kissela BM, Kleindorfer D.

Acad Emerg Med. 2016 Oct;23(10):1128-1135. doi: 10.1111/acem.13029. Epub 2016 Sep 27.

41.

Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke.

Anderson CS, Robinson T, Lindley RI, Arima H, Lavados PM, Lee TH, Broderick JP, Chen X, Chen G, Sharma VK, Kim JS, Thang NH, Cao Y, Parsons MW, Levi C, Huang Y, Olavarría VV, Demchuk AM, Bath PM, Donnan GA, Martins S, Pontes-Neto OM, Silva F, Ricci S, Roffe C, Pandian J, Billot L, Woodward M, Li Q, Wang X, Wang J, Chalmers J; ENCHANTED Investigators and Coordinators.

N Engl J Med. 2016 Jun 16;374(24):2313-23. doi: 10.1056/NEJMoa1515510. Epub 2016 May 10. Erratum in: N Engl J Med. 2018 Apr 12;378(15):1465-1466.

42.

Early Versus Late Assessment of Stroke Outcome.

Lees KR, Selim MH, Molina CA, Broderick JP.

Stroke. 2016 May;47(5):1416-9. doi: 10.1161/STROKEAHA.115.011153. Epub 2016 Feb 19. Review. No abstract available.

43.

Incontinence and gait disturbance after intraventricular extension of intracerebral hemorrhage.

Woo D, Kruger AJ, Sekar P, Haverbusch M, Osborne J, Moomaw CJ, Martini S, Hosseini SM, Ferioli S, Worrall BB, Elkind MS, Sung G, James ML, Testai FD, Langefeld CD, Broderick JP, Koch S, Flaherty ML.

Neurology. 2016 Mar 8;86(10):905-11. doi: 10.1212/WNL.0000000000002449. Epub 2016 Feb 5.

44.

Withdrawal of Antithrombotic Agents and the Risk of Stroke.

Wagner ML, Khoury JC, Alwell K, Rademacher E, Woo D, Flaherty ML, Anderson AM, Adeoye O, Ferioli S, Kissela BM, Kleindorfer D, Broderick JP.

J Stroke Cerebrovasc Dis. 2016 Apr;25(4):902-6. doi: 10.1016/j.jstrokecerebrovasdis.2016.01.006. Epub 2016 Jan 28.

45.

Acute Ischemic Stroke with Very Early Clinical Improvement: A National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trials Exploratory Analysis.

Balucani C, Levine SR, Khoury JC, Khatri P, Saver JL, Broderick JP.

J Stroke Cerebrovasc Dis. 2016 Apr;25(4):894-901. doi: 10.1016/j.jstrokecerebrovasdis.2015.10.028. Epub 2016 Jan 26.

PMID:
26825352
46.

Effect of endovascular reperfusion in relation to site of arterial occlusion.

Lemmens R, Hamilton SA, Liebeskind DS, Tomsick TA, Demchuk AM, Nogueira RG, Marks MP, Jahan R, Gralla J, Yoo AJ, Yeatts SD, Palesch YY, Saver JL, Pereira VM, Broderick JP, Albers GW, Lansberg MG; DEFUSE 2, IMS III, STAR, and SWIFT trialists; DEFUSE 2 IMS III STAR and SWIFT trialists.

Neurology. 2016 Feb 23;86(8):762-70. doi: 10.1212/WNL.0000000000002399. Epub 2016 Jan 22.

47.

The National Institutes of Health StrokeNet: A User's Guide.

Broderick JP, Palesch YY, Janis LS; National Institutes of Health StrokeNet Investigators.

Stroke. 2016 Feb;47(2):301-3. doi: 10.1161/STROKEAHA.115.011743. Epub 2015 Dec 29. No abstract available.

48.

Organizational Update: American Stroke Association Stroke Council Update.

Derdeyn CP, Broderick JP, Furie K.

Stroke. 2016 Jan;47(1):e16-7. doi: 10.1161/STROKEAHA.115.011517. Epub 2015 Dec 8. Review. No abstract available.

PMID:
26645259
49.

Transitions of Care for Stroke Patients: Opportunities to Improve Outcomes.

Broderick JP, Abir M.

Circ Cardiovasc Qual Outcomes. 2015 Oct;8(6 Suppl 3):S190-2. doi: 10.1161/CIRCOUTCOMES.115.002288. No abstract available.

PMID:
26515208
50.

Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Data.

Broderick JP, Berkhemer OA, Palesch YY, Dippel DW, Foster LD, Roos YB, van der Lugt A, Tomsick TA, Majoie CB, van Zwam WH, Demchuk AM, van Oostenbrugge RJ, Khatri P, Lingsma HF, Hill MD, Roozenbeek B, Jauch EC, Jovin TG, Yan B, von Kummer R, Molina CA, Goyal M, Schonewille WJ, Mazighi M, Engelter ST, Anderson CS, Spilker J, Carrozzella J, Ryckborst KJ, Janis LS, Simpson KN; IMS III Investigators; MR CLEAN Investigators.

Stroke. 2015 Dec;46(12):3416-22. doi: 10.1161/STROKEAHA.115.011397. Epub 2015 Oct 20. Erratum in: Stroke. 2016 Jan;47(1):e21. IMS II [corrected to IMS III Investigators].

Supplemental Content

Loading ...
Support Center